Mar 13, 2026 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – March 13, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the second tranche...
Feb 27, 2026 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 27, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the first tranche...
Feb 2, 2026 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce the terms of a proposed non-brokered...
Jan 27, 2026 | Press Releases
PITTSBURGH and TORONTO, Jan. 27, 2026 (GLOBE NEWSWIRE) — Sharp Therapeutics Corp. (“Sharp” or the “Company”) (TSX-V: SHRX) (OTCQB: SHRXF), a biotechnology company developing small-molecule therapeutics for genetic diseases, announced...
Dec 19, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – December 19, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”), is pleased to announce that the non-brokered private...